|
1
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality
Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France:
International Agency for Research on Cancer; 2013 http://globocan.iarc.frJanuary 16–2015
|
|
2
|
Keane MG and Johnson GJ: Early diagnosis
improves survival in colorectal cancer. Practitioner. 256:15–18.
2012.PubMed/NCBI
|
|
3
|
Chen H, Zucknick M, Werner S, Knebel P and
Brenner H: Head-to-head comparison and evaluation of 92 plasma
protein biomarkers for early detection of colorectal cancer in a
true screening setting. Clin Cancer Res. 21:3318–3326. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gonzalez-Pons M and Cruz-Correa M:
Colorectal cancer biomarkers: Where are we now? Biomed Res Int.
2015:1490142015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitsukawa K, Lu X and Bartfai T: Galanin,
galanin receptorss, and drug targetsGalanin. Hökfelt T: 102.
Springer; Basel: pp. 7–9. 2010, View Article : Google Scholar
|
|
6
|
Burleigh DE and Furness JB: Distribution
and actions of galanin and vasoactive intestinal peptide in the
human colon. Neuropeptides. 16:77–82. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
von Rosenvinge EC and Raufman JP:
Gastrointestinal peptides and regulation of gastric acid secretion.
Curr Opin Endocrinol Diabetes Obes. 17:40–43. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barreto SG, Carati CJ, Toouli J and
Saccone GT: The islet-acinar axis of the pancreas: More than just
insulin. Am J Physiol Gastrointest Liver Physiol. 299:G10–G22.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bauer FE, Hacker GW, Terenghi G, Adrian
TE, Polak JM and Bloom SR: Localization and molecular forms of
galanin in human adrenals: Elevated levels in pheochromocytomas. J
Clin Endocrinol Metab. 63:1372–1378. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grenbäck E, Bjellerup P, Wallerman E,
Lundblad L, Anggård A, Ericson K, Aman K, Landry M, Schmidt WE,
Hökfelt T and Hulting AL: Galanin in pituitary adenomas. Regul
Pept. 117:127–139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tuechler C, Hametner R, Jones N, Jones R,
Iismaa TP, Sperl W and Kofler B: Galanin and galanin receptor
expression in neuroblastoma. Ann NY Acad Sci. 863:438–441. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sugimoto T, Seki N, Shimizu S, Kikkawa N,
Tsukada J, Shimada H, Sasaki K, Hanazawa T, Okamoto Y and Hata A:
The galanin signaling cascade is a candidate pathway regulating
oncogenesis in human squamous cell carcinoma. Genes Chromosomes
Cancer. 48:132–142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gilaberte Y, Vera J, Coscojuela C, Roca
MJ, Parrado C and González S: Expression of galanin in melanocytic
tumors. Actas Dermosifiliogr. 98:24–34. 2007.(In Spanish).
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim KY, Kee MK, Chong SA and Nam MJ:
Galanin is up-regulated in colon adenocarcinoma. Cancer Epidemiol
Biomarkers Prev. 16:2373–2378. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ries LA, Wingo PA, Miller DS, Howe HL,
Weir HK, Rosenberg HM, Vernon SW, Cronin K and Edwards BK: The
annual report to the nation on the status of cancer, 1973–1997,
with a special section on colorectal cancer. Cancer. 88:2398–2424.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Godlewski J and Łakomy IM: Changes in
vasoactive intestinal peptide, pituitary adenylate cyclase-
activating polypeptide and neuropeptide Y-ergic structures of the
enteric nervous system in the carcinoma of the human large
intestine. Folia Histochem Cytobiol. 48:208–216. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Godlewski J and Pidsudko Z: Characteristic
of galaninergic components of the enteric nervous system in the
cancer invasion of human large intestine. Ann Anat. 194:368–372.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Godlewski J: Morphological changes in the
enteric nervous system caused by carcinoma of the human large
intestine. Folia Histochem Cytobiol. 48:157–162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Godlewski J, Krazinski BE, Kiezun J,
Kwiatkowski P, Sulik M, Tenderenda M, Biernat W and Kmiec Z: PLAGL1
protein is differentially expressed in the nephron segments and
collecting ducts in human kidney. Folia Histochem Cytobiol.
53:96–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Furness JB: Structure of the enteric
nervous systemThe Enteric Nervous System. Wiley-Blackwell; Hoboken,
NJ: pp. 62006
|
|
21
|
Nagayoshi K, Ueki T, Tashiro K, Mizuuchi
Y, Manabe T, Araki H, Oda Y, Kuhara S and Tanaka M: Galanin plays
an important role in cancer invasiveness and is associated with
poor prognosis in stage II colorectal cancer. Oncol Rep.
33:539–546. 2015.PubMed/NCBI
|
|
22
|
Tadros TS, Strauss RM, Cohen C and Gal AA:
Galanin immunoreactivity in paragangliomas but not in carcinoid
tumors. Appl Immunohistochem Mol Morphol. 11:250–252. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berger A, Santic R, Almer D,
Hauser-Kronberger C, Huemer M, Humpel C, Stockhammer G, Sperl W and
Kofler B: Galanin and galanin receptors in human gliomas. Acta
Neuropathol. 105:555–560. 2003.PubMed/NCBI
|
|
24
|
Skotheim RI, Lind GE, Monni O, Nesland JM,
Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW
and Lothe RA: Differentiation of human embryonal carcinomas in
vitro and in vivo reveals expression profiles relevant to normal
development. Cancer Res. 65:5588–5598. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Benya RV, Marrero JA, Ostrovskiy DA,
Koutsouris A and Hecht G: Human colonic epithelial cells express
galanin-1 receptors, which when activated cause Cl- secretion. Am J
Physiol. 276:G64–G72. 1999.PubMed/NCBI
|
|
26
|
Lang R, Gundlach AL, Holmes FE, Hobson SA,
Wynick D, Hökfelt T and Kofler B: Physiology, signaling and
pharmacology of galanin peptides and receptors: Three decades of
emerging diversity. Pharmacol Rev. 67:118–175. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kofler B, Berger A, Santic R, Moritz K,
Almer D, Tuechler C, Lang R, Emberger M, Klausegger A, Sperl W and
Bauer JW: Expression of neuropeptide galanin and galanin receptors
in human skin. J Invest Dermatol. 122:1050–1053. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stevenson L, Allen WL, Turkington R,
Jithesh PV, Proutski I, Stewart G, Lenz HJ, Van Schaeybroeck S,
Longley DB and Johnston PG: Identification of galanin and its
receptor GalR1 as novel determinants of resistance to chemotherapy
and potential biomarkers in colorectal cancer. Clin Cancer Res.
18:5412–5426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tjomsland V and El-Salhy M: Effects of
single, double or triple combinations of octreotide, galanin and
serotonin on a human pancreatic cancer cell line. Histol
Histopathol. 20:537–541. 2005.PubMed/NCBI
|
|
30
|
Seufferlein T and Rozengurt E: Galanin,
neurotensin, and phorbol esters rapidly stimulate activation of
mitogen-activated protein kinase in small cell lung cancer cells.
Cancer Res. 56:5758–5764. 1996.PubMed/NCBI
|
|
31
|
Hammond PJ, Smith DM, Akinsanya KO, Mufti
WA, Wynick D and Bloom SR: Signaling pathways mediating secretory
and mitogenic responses to galanin and pituitary adenylate
cyclase-activating polypeptide in the 235-1 clonal rat lactotroph
cell line. J Neuroendocrinol. 8:457–464. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kanazawa T, Misawa K, Misawa Y, Uehara T,
Fukushima H, Kusaka G, Maruta M and Carey TE: G-protein-coupled
receptors: Next generation therapeutic targets in head and neck
cancer? Toxins (Basel). 7:2959–2984. 2015. View Article : Google Scholar : PubMed/NCBI
|
